The performance of 5 core set measure in ACR-CRISS in recent trials was explored, and their ability to discern the active medication group from placebo in patients with diffuse cutaneous systemic sclerosis (dcSSc), was assessed.
A case report of a man with plaque psoriasis and comorbidities that include psoriatic arthritis and ulcerative colitis.
A novel study investigates an in-class IL-23 inhibitor switch from guselkumab to risankizumab for patients with psoriasis.
The classification and severity of acne and rosacea in women was characterized and the co-occurrence triggers assessed.
The effectiveness and safety of 25% trichloroacetic acid (TCA) alone or followed by manual dermasanding for the treatment of mild and moderate acne scars was evaluated.
Adolescent sleep deficiency as an increased future risk for prescription opioid misuse was examined in a large nationally, representative database designed to track health behaviors and outcomes from adolescence to early adulthood.
Brodalumab’s safety and effectiveness in real-world clinical settings for treatment of psoriasis was evaluated.
Data was analyzed to determine if the SA-CIDES could accurately be used in the estimation of involved body surface area for patients with psoriasis and eczema.
The association of ustekinumab therapy initiation and increased risk for severe cardiovascular events was assessed.
The utility of screening with hemoglobin A1c (HbA1c) in a dermatology clinic to detect
undiagnosed dysglycemia and diabetes in patients with hidradenitis suppurativa was evaluated.
